The Bradford Hill Trap: How Acetaminophen MDL Plaintiffs Lost 600 Cases

Verify it yourself — free, no login

See how AI medical-record review links every fact to the exact Bates page that proves it — click any citation and jump straight to the record.

See the 60-second demo →

By John Mahoney · Founder, MedLegal AI · May 2, 2026

In December 2023, just as the FRE 702 amendment took effect, Judge Denise Cote issued the opinion that effectively ended the Acetaminophen ASD-ADHD MDL. Five plaintiff general-causation experts excluded. In September 2024, after plaintiffs were given a second bite with replacement experts, the remaining experts went the same way. With no admissible general-causation testimony, the MDL collapsed and summary judgment followed for more than 600 plaintiffs.

The exclusions were not about credentials. The experts were concededly qualified. The exclusions were about Bradford Hill. Specifically, they were about Bradford Hill done badly — and the way Bradford Hill is usually done in mass-tort general-causation reports.

If you are a plaintiff attorney with any case riding on epidemiologic causation, the Acetaminophen MDL is the case you have to read like a Daubert motion against your own expert.

What Happened in the Acetaminophen MDL

The plaintiffs alleged that prenatal acetaminophen use caused autism spectrum disorder and attention-deficit/hyperactivity disorder in their children. To prove general causation, the MDL leadership retained five experts spanning epidemiology, toxicology, and pediatrics. Each expert applied the Bradford Hill framework to argue that the published epidemiologic literature supported a causal link between prenatal acetaminophen and the children's diagnoses.

Judge Cote excluded all five.

The reasoning is the part every plaintiff attorney needs internalized. The court did not say Bradford Hill was an unreliable methodology. It said these experts had not reliably applied Bradford Hill. Three specific findings:

  1. Cherry-picked studies. The experts had highlighted positive epidemiology studies and downplayed or ignored negative ones. The court treated the asymmetry as evidence that the methodology was result-driven rather than rigorously applied.
  2. Bradford Hill criteria invoked but not weighted. Bradford Hill is a nine-factor framework — strength of association, consistency, specificity, temporality, biological gradient, plausibility, coherence, experiment, and analogy. Listing the criteria is not the same as weighing them. The court found the experts had invoked criteria without explaining how each was weighted, which factors carried the analysis, and why.
  3. A "shared" Bradford Hill workup. Some of the experts had relied on a Bradford Hill weighting performed by another expert in the same case. The court rejected this as not a methodology that has been subjected to peer review. Each expert opining on general causation has to do the workup themselves. Sharing is not science.

A fourth piece of the opinion was the rejection of a "transdiagnostic" approach that bundled ASD and ADHD into a single causal analysis. The court called the aggregation a non-peer-reviewed methodology, an additional reliability problem on top of the Bradford Hill issues.

When plaintiffs were given a second bite with replacement experts in 2024, the same problems repeated. The MDL ended on general-causation grounds.

Why It Matters for Plaintiff Attorneys

Bradford Hill is the central methodology for proving general causation in toxic-tort and pharmaceutical cases. It is also, in 2026, the most heavily attacked methodology in motion practice. Every recent mass-tort exclusion that turns on epidemiology has, somewhere in its reasoning, a Bradford Hill failure.

The Acetaminophen MDL is the canonical example, but the pattern is broader:

What is striking about the Acetaminophen opinion is that the MDL leadership had every resource. The experts were qualified. The funding was there. The case was high-profile. And the methodology still failed.

The implication for plaintiff attorneys at smaller firms is sobering. If MDL leadership cannot reliably apply Bradford Hill at the outset, the typical solo-to-mid-size firm running an individual toxic-tort case is, by default, even more exposed. The defense bar knows this. The motion templates are now in widespread circulation.

How to Avoid This in Your Next Case

Four concrete steps:

1. Require a written Bradford Hill weighting for each of the nine factors. The report should have a separate paragraph — or a separate section — for each factor. Each paragraph should state: (a) what evidence in the literature bears on this factor, (b) what weight the expert assigns to this factor, and (c) why. Any factor that is invoked but not weighted should be either dropped or developed. Listing the criteria is not enough.

2. Address the negative studies head-on. A causation report that cites only positive epidemiology is the easiest possible Daubert motion to write. The literature search should be exhaustive, the negative studies should be acknowledged, and the report should explain — with specific reference to study quality, statistical power, exposure measurement, or confounders — why the negative studies do not undermine the causal inference. If the negative studies are stronger than the positive ones, that is a finding to surface for case strategy, not to bury in the report.

3. Each expert performs the Bradford Hill workup independently. The Acetaminophen opinion's specific concern about a "shared" weighting is not theoretical. If you have two experts who reach the same conclusion via the same Bradford Hill workup, the defense will argue that one of them is reciting the other. Have each expert sit with the literature and weight independently. Memorialize the independent weighting in each expert's file.

4. Consider whether the diagnoses really aggregate. The Acetaminophen MDL was hurt by the "transdiagnostic" framing — bundling ASD and ADHD into one causal claim. Whether your case bundles related diagnoses is a strategic decision with Daubert implications. If the literature treats the conditions separately, the report should too.

A broader point: Bradford Hill is the methodology, but the methodology only works if the literature search underneath it is genuinely exhaustive. The single most common defect in plaintiff Bradford Hill workups is selection bias in the literature search itself — pulling the studies the expert already knew, missing the studies the defense will surface in motion practice. That is a fixable defect, but only if it is fixed before the report is filed.

How a Daubert Workup Tool Can Help

MedLegal AI's Daubert workup tool ships a Bradford Hill fidelity check for every report involving epidemiologic causation. The tool requires each of the nine Bradford Hill factors to be individually addressed in the report, with study-by-study citations, and flags any factor that is invoked but not weighted. The tool also runs a literature-search check: if the expert cites N studies supporting the causal hypothesis but the published literature contains M studies cutting against it, and M is more than a third of N, the tool flags potential cherry-picking before the report is signed. The point is to prepare smarter for Daubert challenges — to give your expert a methodology audit that mirrors the one a federal MDL judge would run. You can run a free Daubert workup on your expert here.

Bottom Line

The Acetaminophen MDL ended for one reason: the Bradford Hill workup did not survive Daubert. Six hundred families lost their cases. The fix for any plaintiff attorney with epidemiologic causation in their case is not abstract. Audit the literature search for negative studies the expert has missed. Require a written, factor-by-factor weighting in the report. Have each expert do the workup independently. The cases that survive Daubert in 2026 will be the ones whose Bradford Hill sections are unrecognizable from the Acetaminophen experts'.

Run a free Daubert workup on your expert.


MedLegal AI is software, not a law firm. We do not provide legal advice. All AI-generated outputs require independent review by a licensed attorney.

Run a free Daubert workup on your expert

Six-pattern audit on a sample case in 90 seconds. No credit card.

Try the free Daubert workup →
MedLegal AI is software, not a law firm. We do not provide legal advice and no attorney-client relationship is created by use of this service. All outputs are AI-generated and must be independently reviewed by a licensed attorney before use in any legal proceeding, expert report, or client communication.
See the AI cite its source — no login
Most legal AI is wrong 17–33% of the time. Watch MedLegal AI pin every finding to the exact record page — click any citation and it jumps to the line that proves it.
Watch the 30-second demo →